
News|Articles|July 1, 2002
Neurontin (Gabapentin) Pfizer Inc.
New Indications: First approval of oral treatment for postherpetic neuralgia
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























